What Are the Treatment Options for Patients with Low-Risk Myelodysplastic Syndromes?

A roundtable discussion, moderated by Guillermo Garcia-Manero, MD, Blood Cancers Today Associate Editor, of the University of Texas MD Anderson Cancer Center, focused on the latest data in the treatment of low-risk myelodysplastic syndromes. Dr. Garcia-Manero was joined by Jamie Koprivnikar, MD; George Yaghmour, MD; and Sangeetha Venugopal, MD.
In the first segment of the roundtable series, the panel discussed the current slate of treatment options for patients with low-risk myelodysplastic syndromes.